The FDA is about to switch Nasalcrom (cromolyn) to OTC

November 1996

The FDA is about to switch Nasalcrom (cromolyn) to OTC.

It'll be marketed by McNeil Consumer Products...in the same strength as the prescription product.

Suggest trying Nasalcrom for allergic rhinitis. It reduces nasal symptoms...without the side effects that come from using antihistamines or decongestants.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote